Pharmacopeia
TERLIPRESSIN
Core pharmacology
- Class Group
Vasopressin Analogue
- Legacy Cicm Level
Level 2
- Introduction
analogue of vasopressin – Prodrug
Peiptidases Lysine vasopressinused as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help
Longer duration of action than Vasopressin
- Indications Uses
Commonly used to stop bleeding of varices in the food pipe (oesophagus).
Hepatorenal syndrome
- Chemical Pharmaceutics
Prodrug of lysine Vasopressin
- Presentation
IV
- Main Action
Acts at the GPCR Vasopressin receptors
- Mechanism of action
Acts at the GPCR Vasopressin receptors
V1 on vascular smooth muscle - vasoconstrictive
V1 on platelets - increase platelet aggregation
V2 on the nephron - antidiuretic actions- Physiological effects
Vasoconstriction
Increased platelet aggregation
Antidiuretic- Adverse Effects Toxicity
Hyponatraemia with H2O retention
May cause severe vasoconstriction -CVC only
Arrhythmias at higher doses
GIT smooth muscle constriction
cramping, nausea, diarrhoea- Absorption
IV only
- Protein binding
30%
- Volume of distribution
0.5 L/kg
Biphasic plasma curve- Metabolism
minimal
- Excretion
urine
- Half-life
50-70min
- Route And Dose
IV
1-2mg terlipressin acetate (0.85-1.7mg Terlipressin) Q6 hourly